Rubicon Research Limited
Aranda Investments bought 843,372 shares of Rubicon Research for ₹140.00 Cr at ₹1660.00 apiece in a block deal.
A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.
Aranda Investments is a Singapore-based investment vehicle wholly owned by Temasek Holdings, the Singapore state investment company. It has held stakes in Indian listed companies as part of Temasek's portfolio.